Uzbekistan Discusses New Projects with Cadila Pharmaceuticals
Uzbekistan and Cadila Pharmaceuticals discussed creating production facilities, localizing medicine production, and joint projects in BioPharma City.
Uzbekistan's Agency for the Development of the Medical and Pharmaceutical Industry, represented by Director Abdulla Azizov, engaged in discussions with Cadila Pharmaceuticals, a prominent Indian pharmaceutical firm, during a recent trip to India.
The Agency for the Development of the Medical and Pharmaceutical Industry reported that the meeting focused on potential collaborative ventures within the pharmaceutical sector. Key topics included the establishment of contemporary pharmaceutical manufacturing facilities in Uzbekistan, the localization of drug production, the integration of cutting-edge technologies, and the execution of investment projects.
Cadila Pharmaceuticals representatives received an overview of the advantages offered by the BioPharma City pharmaceutical cluster, the favorable environment for international investors, and the potential for joint production and high-tech projects.
Furthermore, both parties deliberated on launching joint initiatives within BioPharma City, enhancing production infrastructure, adopting international quality benchmarks, and broadening cooperation in technology transfer.